ArticleCancer chemotherapy and pharmacology2018

Persistent cytarabine and daunorubicin exposure after administration of novel liposomal formulation CPX-351: population pharmacokinetic assessment.

Mina Nikanjam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.